Search

everythinglearnresearchcommunity

for

Search:↓

Men with male pattern baldness have a higher risk of certain skin cancers, especially on the scalp.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Finasteride may cause kidney damage.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Analog 23 is a promising compound for prostate cancer treatment.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Most women with hyperandrogenism first show acne, and skin conditions like hirsutism and acanthosis nigricans are good indicators of the condition.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

New oral testosterone formulations show potential for safer, effective hormone replacement in men with low testosterone.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Testosterone changes important cell communication proteins in pregnant rats' uteruses, which might affect pregnancy success.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.